Notícia

Scienmag Science Magazine (Reino Unido)

FAPESP webinar will discuss how SARS-COV-2 affects the human brain

Publicado em 01 julho 2021

Renowned scientists will focus on COVID’s impact on the human brain addressing molecular mechanisms from both cellular and organismal viewpoints

The next FAPESP COVID-19 Webinar, set for July 7th, will discuss the impact of COVID-19 on the human brain, which is much wider than previously thought – COVID-19 syndrome includes neurological symptoms in over 30% of patients.

Entitled “What does COVID-19 have to do with the brain?”, the webinar aims to show how understanding SARS-CoV-2’s impacts the human brain is key to improve diagnostics, enhance the development of therapeutic agents and, therefore, help patients. The presentations are expected to address the molecular mechanisms of COVID-19 from both cellular and organismal viewpoints,

The webinar will be broadcasted from 10:00 AM to 12:00 (UTC – 03:00). Academic community and journalists are invited to register at https://fapesp.br/eventos/covid13/registration and join the Webinar on Agência FAPESP’s YouTube Channel (or https://www.youtube.com/watch?v=ZD7apS2d7SE).

Luiz Eugênio Mello, FAPESP’s Scientific Director, will welcome the speakers. The moderator will be Daniel Martins-de Souza, an Associate Professor of Biochemistry at the University of Campinas (UNICAMP) and one of FAPESP’s Area Panel Coordinators (Biology).

Participants will be able to interact via a Q&A panel, sending comments and questions in English and Portuguese to live@fapesp.br.

Four speakers have been invited to contribute with their studies to the webinar’s purpose.

The main paths which can be used by the virus to enter the brain will be explored by Helena Radbruch, a professor at the Institute of Neuropathology, Charité Universitaetsmedizin Berlin

Marcelo Mori, a professor in UNICAMP’s Institute of Biology (IB), will focus on research on virus detection in human brain and its effects.

The professor at the University of São Paulo’s Biomedical Sciences Institute, Jean Pierre Peron, and Marília Zaluar Guimarães, from the D’Or Institute for Research and Education (IDOR) and the Federal University of Rio de Janeiro (UFRJ), will tackle the molecular effects of the virus in preclinical models (in vitro and in vivo).

###

About São Paulo Research Foundation (FAPESP)

The São Paulo Research Foundation (FAPESP) is a public institution with the mission of supporting scientific research in all fields of knowledge by awarding scholarships, fellowships and grants to investigators linked with higher education and research institutions in the State of São Paulo, Brazil. FAPESP is aware that the very best research can only be done by working with the best researchers internationally. Therefore, it has established partnerships with funding agencies, higher education, private companies, and research organizations in other countries known for the quality of their research and has been encouraging scientists funded by its grants to further develop their international collaboration. You can learn more about FAPESP at http://www.fapesp.br/en and visit FAPESP news agency at http://www.agencia.fapesp.br/en to keep updated with the latest scientific breakthroughs FAPESP helps achieve through its many programs, awards and research centers. You may also subscribe to FAPESP news agency at http://agencia.fapesp.br/subscribe.

Media Contact
Daniel Martins-de-Souza
dmsouza@unicamp.br
https://covid19.fapesp.br/549 

Essa notícia também repercutiu nos veículos:
Koliasa (Suécia) News Break (EUA) Health and Fitness News Science News 7thSpace